Viewing Study NCT03226769


Ignite Creation Date: 2025-12-24 @ 10:47 PM
Ignite Modification Date: 2026-02-24 @ 10:52 AM
Study NCT ID: NCT03226769
Status: COMPLETED
Last Update Posted: 2020-10-30
First Post: 2017-07-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of TrueTear™ for the Treatment of Meibomian Gland Disease
Sponsor: Allergan
Organization:

Study Overview

Official Title: Prospective, Open-Label, Randomized, Proof of Concept Study Exploring Application of TrueTear™ for the Treatment of Meibomian Gland Disease
Status: COMPLETED
Status Verified Date: 2020-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will compare the safety and efficacy of TrueTear™ to standardized moist heat compress (Thermalon® Dry Eye Compress) for the treatment of Meibomian Gland Disease (MGD).
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: